FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1784644 · Received July 30, 2010

Report

Report Number
2024168-2010-01535
Event Type
Injury
Date Received
July 30, 2010
Date of Event
July 7, 2010
Report Date
July 7, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). (B)(4). THE STENT REMAINS IN THE PATIENT. THE LOT NUMBER WAS PROVIDED. REVIEW OF THE DEVICE HISTORY RECORD IS FORTHCOMING. A FOLLOW-UP WILL BE SUBMITTED WITH ALL RELEVANT INFORMATION. THE STENT: 3.0 X 28 MM XIENCE V (PART 1009529-28, LOT 0031041), IS BEING FILED UNDER A SEPARATE MFR.

Description of Event or Problem · 1

DEVICE ISSUE: NONE. ADVERSE EVENT: DISSECTION. ONSET OF ADVERSE EVENT: DURING THE PROCEDURE. IT WAS REPORTED THAT RESISTANCE WAS MET WHEN THE 3.5 X 18 XIENCE V STENT WAS ADVANCED IN A PREDILATED, TORTUOUS AND CALCIFIED, BUT UNSPECIFIED TARGET LESION. AFTER THE XIENCE V STENT WAS DEPLOYED, A DISSECTION WAS IDENTIFIED. A 3.0 X 28 XIENCE V STENT WAS IMPLANTED TO SEAL THIS DISSECTION, BUT ALSO RESULTED IN A SECOND DISSECTION. TWO NON-ABBOTT BARE METAL STENTS WERE THEN IMPLANTED TO TREAT THESE DISSECTIONS. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 0031041

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention STENT: 3.0 X 28 MM XIENCE V| (PART 1009529-28, LOT 0031041)